Company Filing History:
Years Active: 2022
Title: Chetan Balubhai Patel: Innovator in Pharmaceutical Chemistry
Introduction
Chetan Balubhai Patel is a notable inventor based in Mysore, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of angiotensin receptor blockers. His innovative work has led to advancements in the preparation of these important compounds.
Latest Patents
Chetan Patel holds a patent for the "Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof." This invention focuses on a process for creating angiotensin receptor blockers, specifically Losartan and its potassium salt, while minimizing azido impurities to less than 10 ppm. The process is designed to be simple, economical, and industrially efficient, making it a valuable contribution to pharmaceutical manufacturing.
Career Highlights
Chetan Patel is currently associated with Jubilant Generics Limited, where he applies his expertise in pharmaceutical development. His work has been instrumental in enhancing the quality and safety of medications used to treat various health conditions.
Collaborations
Chetan has collaborated with several professionals in his field, including Saji Thomas and Rajendra Shekhawat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of knowledge.
Conclusion
Chetan Balubhai Patel's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work not only advances scientific understanding but also improves the quality of life for patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.